Predictors of adverse diastolic remodeling in non-diabetic patients presenting with ST-elevation myocardial infarction

Table 3 Age and gender adjusted association of candidate baseline markers with E/e′ at 4 months after STEMI and change in E/e′ between hospitalization and follow-up

Predictor	E/e′ at follow-up			Change in E/e’
Predictor	β	SE	P value	β	SE	P value
Hypertension	0.97	0.32	< 0.01
Systolic blood pressure, mm/Hg per 10	0.13	0.06	0.03
Multivessel disease	1.10	0.30	< 0.01
Myocardial blush grade ≤ 1				1.25	0.49	0.01
Glucose, mmol/L	0.20	0.07	< 0.01
HbA_1c, %	0.47	0.27	0.08
Potassium, nnol/L	− 0.74	0.39	0.05
AST, U/L				− 0.97	0.29	< 0.01
LDH, U/L	0.37	0.19	0.06	− 0.56	0.19	< 0.01
CK-total, U/L per doubling	0.28	0.12	0.03	− 0.28	0.12	0.02
CK-MB, U/L per doubling				− 0.31	0.13	0.02
NT-proBNP, ng/L per doubling	0.23	0.09	0.01	− 0.18	0.09	0.04
Peak CK-total, U/L per doubling	0.24	0.08	< 0.01	− 0.16	0.08	0.07
Peak CK-MB, U/L per doubling	0.26	0.10	0.01	− 0.19	0.10	0.05
Peak NT-proBNP, ng/L per doubling	0.17	0.10	0.09

β Beta, SE Standard error, HbA_1c Glycated hemoglobin, AST Aspartate transferase, LDH Lactate dehydrogenase, CK Total creatine kinase, CK-MB Myocardial band of creatine kinase, NT-proBNP N-terminal pro-brain natriuretic peptide

ISSN: 1471-2261